Summary for 6AZW
Entry DOI | 10.2210/pdb6azw/pdb |
Related | 6AZU 6AZV |
Descriptor | Indoleamine 2,3-dioxygenase 1, (2R)-N-(4-cyanophenyl)-2-[cis-4-(quinolin-4-yl)cyclohexyl]propanamide (2 entities in total) |
Functional Keywords | ido1/fxb-001116 crystal structure, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Cytoplasm, cytosol : P14902 |
Total number of polymer chains | 2 |
Total formula weight | 89477.18 |
Authors | Lewis, H.A.,Lammens, A.,Steinbacher, S. (deposition date: 2017-09-13, release date: 2018-03-21, Last modification date: 2023-08-16) |
Primary citation | Nelp, M.T.,Kates, P.A.,Hunt, J.T.,Newitt, J.A.,Balog, A.,Maley, D.,Zhu, X.,Abell, L.,Allentoff, A.,Borzilleri, R.,Lewis, H.A.,Lin, Z.,Seitz, S.P.,Yan, C.,Groves, J.T. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. Proc. Natl. Acad. Sci. U.S.A., 115:3249-3254, 2018 Cited by PubMed: 29531094DOI: 10.1073/pnas.1719190115 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.78 Å) |
Structure validation
Download full validation report